Details of the Drug

General Information of Drug (ID: DMVGJ84)

• Drug Name: Ii-Key hybrid peptide vaccine

Indication

Disease Entry	ICD 11	Status	REF
Influenza A virus H1N1 infection	1E30	Phase 1	[1]

• Cross-matching ID: TTD ID: D05KOP

References

• [1] Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. Clin Cancer Res. 2010 Jul 1;16(13):3495-506.